ABOUT US PRODUCT PIPELINE TECHNOLOGY PARTNERS  INVESTORS NEWS  CAREERS       Home  Contact  Search  Site Map   Corporate Profile  Financial Information  Corporate Governance  Reports & Presentations  Press Releases  IR Calendar & Events  Shareholder Services Sign up for messages to be conveniently delivered to your email whenever new company information is posted. Sign up here to receive Crucell's newsletter. Dutch    German                                 2006 |2005 | 2004 | 2003 | 2002 | 2001 | 2000   08 Dec 2003 Crucell Signs PER.C6(TM) Cell Line Development Service Agreement 21 Nov 2003 Crucell Presents Update on In-house Product Development Programs at Analyst Meeting 19 Nov 2003 Crucell Appoints Jean-Yves Guichoux, Executive Vice President, Development 17 Nov 2003 Crucell to Webcast Analyst Day on November 21st, 2003 14 Nov 2003 Crucell Presents Encouraging Results of its Malaria Vaccine Program 27 Oct 2003 Crucell Announces Resignation of M.A. de Haan 22 Oct 2003 Crucell Announces Malaria Vaccine Program in Collaboration with New York University, Walter Reed Army Institute of Research and GlaxoSmithKline 14 Oct 2003 Crucell and Gene Medicine Japan Initiate Manufacturing Partnership for Asia 13 Oct 2003 Crucell Announces Third Quarter 2003 Results 25 Sep 2003 Crucell and Novavax Announce PER.C6(TM) Vaccine Manufacturing Services 22 Sep 2003 Joint Crucell and Harvard Medical School Study Demonstrates the Potential of New Vaccine Delivery System for Diseases like HIV/AIDS 19 Sep 2003 Crucell - DSM Biologics Alliance to Present New PER.C6(TM) Data at Biophex Conference on September 25, 2003 19 Sep 2003 Crucell to Present at 2003 UBS Global Life Sciences Conference 03 Sep 2003 Crucell and Kimron Veterinary Institute Announce Anticipated Approval of West Nile Veterinary Vaccine Early 2004 28 Aug 2003 Crucell Hires Redington, Inc. to Expand its Reach and Raise Awareness in the US Investment Community 12 Aug 2003 Crucell and GeneMax Enter PER.C6(TM) License Agreement in Gene Delivery Field to Advance Clinical Trial 07 Aug 2003 Ebola Vaccine Holds Promise for Protection in Humans 14 Jul 2003 Crucell Announces Second Quarter 2003 Results 11 Jun 2003 Crucell is Developing West Nile Vaccine for Humans 11 Jun 2003 Crucell and Kimron Veterinary Institute Sign License Agreement for West Nile Veterinary Vaccine 03 Jun 2003 Crucell Expands Relationship with Merck & Co. 03 Jun 2003 Crucell and Merck & Co. Sign PER.C6(TM) Licensing Agreement for Therapeutic Protein Production 29 Apr 2003 Dr. C.E. Wilhelmsson and Mr. S. Lance nominated to Crucell's Supervisory Board 14 Apr 2003 Crucell publishes First Quarter 2003 Results 07 Apr 2003 Invitation Conference Call Q1 Results 2003 14 Feb 2003 Crucell Signs PER.C6(TM) License with Targeted Genetics 27 Jan 2003 Crucell and Aventis Pasteur Sign License Agreement for Manufacturing Viral Vaccines 27 Jan 2003 Crucell Reports 2002 Annual Results 16 Jan 2003 Crucell Signs PER.C6(TM) Antibody Production Agreement with Centocor   Home    Contact    Search    Site Map
© Crucell 2006 | Disclaimer